Blog Posts

340B Provider-Drugmaker Lobbying Group Adds Hospital, Drugmaker: Key Thune Staffer Departs for Private Sector

The 340B Working Table has added Boston Medical Center Health System and Takeda Pharmaceuticals America to its list of members.
A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added another major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genentech Tightens Contract Pharmacy Restrictions to Require Hospital Claims Data, Targets 340B Drug Redistribution; 340B Lawyer Pushes Back

Genentech updated its contract pharmacy restrictions to impose new claims data submissions and prevent covered entities from shipping 340B drugs to other locations through “alternate distribution models” or other channels.
A California-based drugmaker this week updated its contract pharmacy restrictions to impose new claims data submissions for hospitals and prevent [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Key Briefs in 8th Circuit, Utah, South Dakota; Motion Filed in 5th Circuit

Key briefs and motions were filed recently in the 8th Circuit and 5th Circuit Appeals Courts, as well as federal district courts in Utah and South Dakota.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Red Chip Enterprises

Q: Tell us some interesting details about your company’s history.

Red Chip entered the 340B scene 24 years ago, just as Hemophilia Treatment Centers (HTCs) were looking to increase

Read More »

News Alert

RFK Jr. Tells Senate Panel 340B Program ‘Controversial’ But Important to Rural Hospitals; HHS Releases MFN Targets for Drugmakers

HHS Secretary Robert F. Kennedy Jr. told a Senate subcommittee Tuesday that the 340B program plays an important role for rural hospitals despite being “very controversial."
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. told a U.S. Senate subcommittee Tuesday that the 340B program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Applaud Federal Judge’s 340B Rebate Ruling as Drugmakers Mull Next Steps

340B stakeholders are reacting to U.S District Judge Dabney Friedrich's May 15 ruling on a series of controversial drugmaker 340B rebate lawsuits.
A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judges Allows 340B Hospital Advocacy Group to Intervene in J&J Rebate Lawsuit

A federal district judge in Washington, D.C. will allow a hospital advocacy group to intervene in another drugmaker 340B rebate lawsuit.
A federal district judge last Friday allowed a key hospital trade group to intervene in Johnson & Johnson’s (J&J) lawsuit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Safeguarding Your 340B Program

SPONSORED CONTENT

Introduction: Navigating Political Headwinds

As the 2025 political season heats up, federally qualified health centers (FQHCs), hospitals, STD clinics, Ryan White grantees, and other covered entities must brace for another round of uncertainty. With renewed debates around entitlement

Read More »

California Assembly Passes 340B Contract Pharmacy Protections for Grantees, Sends Bills to Senate

California state assembly members voted by a 44-6 margin to pass a 340B contract pharmacy access bill on May 19.
The California Assembly yesterday approved a bill to prohibit manufacturers from placing 340B contract pharmacy restrictions on grantee covered entities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry-Backed AIDS Group Targets 340B in New Ad Campaign

ADAP Advocacy, a drug industry funded group, recently released a minute-long ad that argues 340B unduly benefits providers and could be rife with “fraud, waste and abuse.”
A pharmaceutical industry-funded HIV/AIDS advocacy group is taking aim at the 340B program—questioning if it’s “too big to fail”—in a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live